Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

CRNT vs SENS: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CRNT Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 6–4 Matrix Metrics)

CRNT Overall Winner 6-Pillar Tally: CRNT 4 – 2 SENS Matrix Metrics: CRNT 6 – 4 SENS

As of Nov 16, 2026, Ceragon Networks Ltd (CRNT) is the stronger overall head-to-head candidate over Senseonics Holdings, Inc. (SENS) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). CRNT carries a Unified Composite Score of 26.6/100 (SELL) at $2.36 (13.7x Forward P/E, 3.5% operating margin), whereas SENS carries 38.8/100 (SELL) at $11.03 (21.0x Forward P/E, -201.0% operating margin).

  • Composite vs. Pillar Nuance: While SENS currently prints a higher short-term Unified Composite Score (38.8/100 SELL vs. CRNT 26.6/100 SELL), CRNT captures the overall institutional head-to-head verdict (6–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (3.5% vs. -201.0% operating margin) and revenue trajectory (+11.7% vs. +141.6% YoY).
  • Defensive Composite Rating Caution: Although CRNT compares more favorably head-to-head, both CRNT (26.6/100 SELL) and SENS (38.8/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
  • Technical & Structure Timing Caution: CRNT is currently in a Breakdown options structure phase (RSI 56.2); meanwhile SENS trades in a Markup technical trend (CONSOLIDATION options phase, RSI 66.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CRNT vs SENS
CRNT NASDAQ Head-to-Head Winner
Ceragon Networks Ltd
Radio & Tv Broadcasting & Communications Equipment
$2.36
-1.26% 1D
Market Cap $217.2M
TTM Revenue $357M
Forward P/E 13.7x
Beta / 30D Vol 1.84β · 77% Vol
Unified Composite Score
26.6 / 100 SELL
Tech 50.0 Fund 35.0 Flow 58.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (1.5% over 20 days), RSI 56
RSI-14: 56.2 · SMA20: $2.19 · SMA50: $2.12
SENS NYSE American
Senseonics Holdings, Inc.
Industrial Instruments For Measurement, Display, And Control
$11.03
+4.25% 1D
Market Cap $569.4M
TTM Revenue $60M
Forward P/E 21.0x
Beta / 30D Vol 1.96β · 102% Vol
Unified Composite Score
38.8 / 100 SELL
Tech 15.0 Fund 43.0 Flow 57.0 Mom 70.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (0.6% over 20 days), RSI 67
RSI-14: 66.7 · SMA20: $9.06 · SMA50: $9.21

6-Pillar Scorecard Institutional Category Breakdown (CRNT 4 – 2 SENS)

Columns: Metric · CRNT · SENS
1. Valuation Multiples CRNT
Forward P/E 13.7x 21.0x
Trailing P/E 15.7x 21.0x
PEG Ratio 8.80x N/M
EV / Revenue 0.6x 9.7x
2. Growth & Scale SENS
Revenue Growth (YoY) +11.7% +141.6%
Earnings Growth (YoY) N/A +0.0%
TTM Revenue (USD) $357M $60M
Market Cap $217.2M $569.4M
3. Profitability & Quality CRNT
Gross Margin 34.1% 58.7%
Operating Margin 3.5% -201.0%
Net Profit Margin -0.3% -204.2%
Return on Equity (ROE) -0.5% -157.3%
4. Balance Sheet & Cash Flow CRNT
Cash Generation (TTM) $13M -$114M
Cash Flow Margin 3.6% N/A
Net Cash / Leverage $6.0M Net Cash $13M Net Debt (0.79x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning SENS
Options Structure Phase BREAKDOWN CONSOLIDATION
Current IV / %ile 43.7% (7th %ile) 68.8% (35th %ile)
Put/Call OI Skew N/A 0.14x (Call-Skewed)
OBV Trend / Tech Phase ACCUMULATION · Markup ACCUMULATION · Markup
6. R&D & Supply-Chain Moat CRNT
OpEx & R&D Intensity 30.6% of Rev ($109M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Communication Equipment Operator Medical Devices Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CRNT (6) vs SENS (4)
Institutional Metric CRNT SENS Criterion Row Edge
Market Capitalization
Scale
$217.2M $569.4M Larger Scale SENS
Trailing P/E Ratio
Valuation
15.7x 21.0x Lower Multiple CRNT
Forward P/E Ratio
Valuation
13.7x 21.0x Lower Multiple CRNT
Revenue Growth (YoY)
Growth
+11.7% +141.6% Higher Growth SENS
Operating Margin (TTM)
Profitability
3.5% -201.0% Higher Margin CRNT
Net Profit Margin
Profitability
-0.3% -204.2% Higher Margin CRNT
Return on Equity (ROE)
Capital Efficiency
-0.5% -157.3% Higher ROE CRNT
52-Week Range Position
Momentum
35% ($2–$3) 68% ($5–$14) Stronger Trend SENS
Beta / 30D Volatility
Risk Regime
1.84β · 77% Vol 1.96β · 102% Vol Lower Realized Risk CRNT
Unified Institutional Score
Composite Signal
26.6 / 100 (SELL) 38.8 / 100 (SELL) Higher Composite SENS
Trailing 12M Revenue (USD)
Operating Scale
$357M $60M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
34.1% 58.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
8.80x PEG · 0.6x EV/Rev N/M PEG · 9.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$13M ($6.0M Net Cash) -$114M ($13M Net Debt (0.79x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon SENS +26.27 pp
CRNT: +15.69% · SENS: +41.96%
3M Horizon SENS +15.08 pp
CRNT: +11.85% · SENS: +26.93%
6M Horizon SENS +104.36 pp
CRNT: -5.98% · SENS: +98.38%
1Y Horizon SENS +67.16 pp
CRNT: +11.32% · SENS: +78.48%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period CRNT Revenue SENS Revenue CRNT Op. Margin SENS Op. Margin Margin Leader
FY2018 $340M $0M 7.6% -4295.1% CRNT
FY2019 $290M $0M 2.6% -2653.6% CRNT
FY2020 $260M $0M -2.9% -5784.4% CRNT
FY2021 $290M $0M 1.7% -4102.0% CRNT
FY2022 $300M $20M -3.7% -418.7% CRNT
FY2023 $350M $20M 6.1% -337.7% CRNT
FY2024 $390M $20M 9.8% -333.0% CRNT
FY2025 $340M $40M 2.1% -193.8% CRNT

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CRNT BREAKDOWN
114d in phase · OBV ACCUMULATION
Current IV 43.7%
IV Percentile 7th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact CRNT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
SENS CONSOLIDATION
37d in phase · OBV ACCUMULATION
Current IV 68.8%
IV Percentile 35th %ile
Put/Call OI Skew 0.14x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact SENS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CRNT Moat Profile Cyclical / Execution-Driven Positioning
Communication Equipment Operator
Competes within the Communication Equipment value chain with $217.2M market capitalization and 3.5% operating margin.
OpEx & R&D Reinvestment 30.6% of Rev ($109M)
90D Engineering Disclosures 0 Published
SENS Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $569.4M market capitalization and -201.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ CRNT vs SENS Key Questions & Quantitative Answers

As of Nov 16, 2026, Ceragon Networks Ltd (CRNT) is the stronger overall head-to-head candidate over Senseonics Holdings, Inc. (SENS) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). CRNT carries a Unified Composite Score of 26.6/100 (SELL) at $2.36 (13.7x Forward P/E, 3.5% operating margin), whereas SENS carries 38.8/100 (SELL) at $11.03 (21.0x Forward P/E, -201.0% operating margin). Composite vs. Pillar Nuance: While SENS currently prints a higher short-term Unified Composite Score (38.8/100 SELL vs. CRNT 26.6/100 SELL), CRNT captures the overall institutional head-to-head verdict (6–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (3.5% vs. -201.0% operating margin) and revenue trajectory (+11.7% vs. +141.6% YoY). Defensive Composite Rating Caution: Although CRNT compares more favorably head-to-head, both CRNT (26.6/100 SELL) and SENS (38.8/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: CRNT is currently in a Breakdown options structure phase (RSI 56.2); meanwhile SENS trades in a Markup technical trend (CONSOLIDATION options phase, RSI 66.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

SENS leads the Growth & Scale pillar: CRNT posts +11.7% YoY revenue growth and N/A YoY earnings growth on $357M TTM revenue (34.1% gross margin, 3.5% operating margin), compared with SENS at +141.6% YoY revenue growth and +0.0% YoY earnings growth on $60M TTM revenue (58.7% gross margin, -201.0% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), CRNT cumulative revenue shifted +0.0% while SENS shifted +100.0%. In operating R&D and SG&A reinvestment, CRNT deploys 30.6% of Rev ($109M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for SENS.

CRNT screens cheaper on headline valuation multiples. CRNT trades at 13.7x Forward P/E, 15.7x Trailing P/E, 8.80x PEG, and 0.6x EV/Revenue (3.6% FCF margin), whereas SENS trades at 21.0x Forward P/E, 21.0x Trailing P/E, N/M PEG, and 9.7x EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CRNT (-0.5% ROE) versus SENS (-157.3% ROE) capital efficiency.

In options market volatility and institutional positioning, CRNT carries 43.7% implied volatility (7th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (1.84β · 77% Vol realized risk). By comparison, SENS carries 68.8% implied volatility (35th %ile, Balanced (25th–60th %ile)), a 0.14x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.96β · 102% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.